U.S. Stem Cell's competitors

U.S. Stem Cell's competitors include Forge Therapeutics, Frequency Therapeutics, Lodo Therapeutics and Endologix
Add company...
U.S. Stem Cell
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Forge Therapeutics
Forge Therapeutics is a biotech that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins.
Frequency Therapeutics
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Lodo Therapeutics
Lodo Therapeutics is a drug discovery and development company.
Endologix
Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.
Founding Date
Founding Date
N/A
Founding Date
2015
Founding Date
2015
Founding Date
2016
Founding Date
1992
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Sunrise, US HQ
Locations
San Diego, US HQ
Locations
Woburn, US HQ
Locations
New York, US HQ
Locations
Irvine, US HQ
Rosmalen, NL
Employees
Employees
3
Employees
14
Employees
287% decrease
Employees
176% increase
Employees
782
Valuation ($)
Valuation ($)
9.7 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
448.6 m
Facebook likes
Facebook likes
1.4 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
132
Twitter followers
Twitter followers
1.8 k
Twitter followers
243
Twitter followers
334
Twitter followers
N/A
Twitter followers
242

Financial

Revenue (est.)
Revenue (est.)
$5.5m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$192.9m (FY, 2016)
Cost of goods
Cost of goods
$1.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$69.1m (FY, 2016)
Gross profit
Gross profit
$3.6m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$123.8m (FY, 2016)
Net income
Net income
($3.5m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($154.7m) (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 15m (about 1 year ago)
Latest funding round
$ 32m (about 1 year ago)
Latest funding round
$ 17m (over 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 15m
Total funding raised
$ 32m
Total funding raised
$ 17m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Forge Therapeutics
HQ
San Diego, US
Employees
14

Forge Therapeutics is a biotech that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins.

View company
Frequency Therapeutics
HQ
Woburn, US
Employees
28↓ 7% decrease

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

View company
Lodo Therapeutics
HQ
New York, US
Employees
17↑ 6% increase

Lodo Therapeutics is a drug discovery and development company.

View company
Endologix
HQ
Irvine, US
Employees
782

Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.

View company